Deepali Suri, President of ICON Biotech, has been published in Pharmaceutical Executive. Her article draws on insights from 163 biotech leaders across North America, EMEA and APAC, supported by a supplementary survey o...
- Home
- News & Events
- In the News
In the News
ICON experts frequently author or contribute to industry trade press.
Filter media
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category. Note - not all categories will display results if selecting a particular year.
-
The role of digital health technology tools in supporting medical adherence
In this article in Pharmaceutical Market Europe, Dr Peter Schueler and Dr Isaac R Rodriguez Chavez outline the role of digital health technology tools in supporting medical adherence. 2022 PM Group
-
The Use of Predictive Analytics to Improve Quality in Clinical Trials Quality Assurance
Rose Kidd, Executive Vice President, Quality and Compliance at ICON, discusses how predictive analytics provide a real opportunity to develop new and innovative processes in the area of QA.
This article is taken from International Pharmaceutical Industry, Volume 14, Issue 3, pages 32-33. Senglobal Ltd
-
The surge of digital health technologies modernising clinical research
Dr. Isaac R. Rodriguez-Chavez outlines the key considerations when developing digital health technologies.
-
Precision medicine
Ewa Kleczyk, Vice President, Advanced & Custom Analytics, offers her insights on the use of precision medicine in clinical trials.
-
The silent problem: Machine learning model failure - How to diagnose and fix ailing machine learning models
This article considers the current issues around the applicability of Machine Learning Models.
Bennett, M. Balusu, J., Hayes, K., & Klecyzk, E. J., The Silent Problem- Machine Learning Model Failure - How to Diagnose and Fix Ailing Machine Learning Models. Cornell University ArxIV. doi: 10.48550/arXiv.2204.10227
-
-
How healthcare can develop through digital innovation
Gerard Quinn and Barbara Skerritt offer their insights into the rapid acceleration of digital innovation in clinical research in the past two years.
-
Will big tech dominate healthcare in the years ahead?
Louisa Roberts, VP of Corporate Development and Partnerships, considers the benefits of partnerships with tech companies.
-
Identifying integrated digital platforms designed for a decentralised future
Matt Harrington, VP of Connected Health Technology Solutions, explores how the use of digital platforms and associated services can contribute to more adaptable, accessible and efficient clinical trials.
-
The path to smarter digital health
Michael Phillips and Kevin Rooney discuss the use of artificial intelligence for the purposes of automation in digital health and pharma.
This article is taken from Innovations in Pharmaceutical Technology Autumn/Winter 2021, pages 39-41. Samedan Ltd